A specific phosphorylation regulates the protective role of αA-crystallin in diabetes
Anne Ruebsam, Jennifer E. Dulle, Angela M. Myers, Dhananjay Sakrikar, Katelyn M. Green, Naheed W. Khan, Kevin Schey, Patrice E. Fort
Anne Ruebsam, Jennifer E. Dulle, Angela M. Myers, Dhananjay Sakrikar, Katelyn M. Green, Naheed W. Khan, Kevin Schey, Patrice E. Fort
View: Text | PDF
Research Article Ophthalmology

A specific phosphorylation regulates the protective role of αA-crystallin in diabetes

Abstract

Neurodegeneration is a central aspect of the early stages of diabetic retinopathy, the primary ocular complication associated with diabetes. While progress has been made to improve the vascular perturbations associated with diabetic retinopathy, there are still no treatment options to counteract the neuroretinal degeneration associated with diabetes. Our previous work suggested that the molecular chaperones α-crystallins could be involved in the pathophysiology of diabetic retinopathy; however, the role and regulation of α-crystallins remained unknown. In the present study, we demonstrated the neuroprotective role of αA-crystallin during diabetes and its regulation by its phosphorylation on residue 148. We further characterized the dual role of αA-crystallin in neurons and glia, its essential role for neuronal survival, and its direct dependence on phosphorylation on this residue. These findings support further evaluation of αA-crystallin as a treatment option to promote neuron survival in diabetic retinopathy and neurodegenerative diseases in general.

Authors

Anne Ruebsam, Jennifer E. Dulle, Angela M. Myers, Dhananjay Sakrikar, Katelyn M. Green, Naheed W. Khan, Kevin Schey, Patrice E. Fort

×

Figure 4

Phosphorylation on serine/threonine residue 148 of αA-crystallin, which is reduced by diabetes, regulates its neuroprotective function.

Options: View larger image (or click on image) Download as PowerPoint
Phosphorylation on serine/threonine residue 148 of αA-crystallin, which ...
The 2 main αA-crystallin products identified by immunoblot (20 and 22 kDa) were immunoprecipitated from mouse and human retinal lysates and analyzed by mass spectrometry (A and B). The level of phosphorylation of the 146–157 peptide was analyzed by multiple reaction monitoring, and the ratio of phosphorylated to nonphosphorylated peptide is graphically represented for (A) 12-week diabetic (D, n = 3) or nondiabetic mice (ND, n = 3) and (B) nondiabetic (ND, n = 6), diabetic without retinopathy (D, n = 3), or diabetic with retinopathy human donors (DR, n = 3). *P ≤ 0.05, significantly different from nondiabetics. (C and E) Effect of αA-crystallin phosphorylation on the threonine residue 148 on retinal neuronal cell survival. Serum deprivation (no FBS) induced cell death was measured in neurons transfected with the empty vector (EV) versus neurons overexpressing WT (αA-WT), the phosphomimetic mutant (αA-T148D), or the nonphosphorylatable mutant (αA-T148A) of αA-crystallin on threonine 148. Cell death was assessed by DNA fragmentation ELISA (C), TUNEL staining (D), and caspase 3/7 activity assay (E). Representative immunofluorescence images of serum-deprived transfected neurons are shown for the TUNEL data (TUNEL in green, αA-crystallin in red, and nuclei in blue; scale bar: 50 μm), while graphic representation of the quantifications are shown for all 3 endpoints. #P ≤ 0.05, ##P ≤ 0.01, ####P ≤ 0.0001, significantly different from serum-starved EV-transfected cells. Each endpoint was measured on a minimum of 3 technical replicates in 3 independent experiments (2 for TUNEL). Statistical analysis was performed by 1-way ANOVA followed by Student-Newman-Keuls test.